Skip to main content

Table 2 Crude and adjusted regression analysis of diagnostic time up to 3 months and independent variables in patients with rheumatoid arthritis in Blumenau, Santa Catarina, Brazil, 2014

From: Prevalence and factors associated with diagnosis of early rheumatoid arthritis in the south of Brazil

Variables

Crude analysis

Adjusted analysis

(PRc)

CI 95%

p

(PRa)

CI 95%

p

Sex (n = 296)

0,146

  

0,154**

 Male

0,84

(0,6-1,0)

 

0,85

(0,6-1,0)

 

 Female

1

  

1

  

Age in years (n = 287)

0,200

  

0,267**

 20–39

1

  

1

  

 40–59

0,83

(0,6-1,0)

 

0,84

(0,6-1,0)

 

  ≥ 60

0,80

(0,6-1,0)

 

0,81

(0,6-1,0)

 

Education in completed years (n = 284)

0,459*

  

0,314**

 0–4

0,93

(0,7-1,1)

 

0,90

(0,7-1,0)

 

 5–8

1,08

(0,9-1,2)

 

1,07

(0,9-1,2)

 

  > 9

1

  

1

  

Current monthly personal income in minimum wages (n = 248)

0,801*

  

0,622**

 Third tertile (higher)

1

  

1

  

 Second tertile

1,01

(0,8-1,2)

 

1,01

(0,8-1,2)

 

 First tertile (lower)

0,97

(0,8-1,1)

 

0,95

(0,7-1,1)

 

Body mass index (Kg/m2) (n = 285)

0,010

  

0,031

  ≤ 24,9

1

  

1

  

 25–29,9

1,18

(0,9-1,4)

 

1,16

(0,9-1,4)

 

  ≥ 30

1,26

(1,0-1,5)

 

1,23

(1,0-1,5)

 

Type of servicee in the last 12 months (n = 269)

0,177

  

0,623**

 Public healthcare system

0,87

(0,7-1,0)

 

0,95

(0,7-1,1)

 

 Supplementary healthcare system

0,95

(0,8-1,1)

 

0,96

(0,8-1,1)

 

 Fee-for-service care

1

  

1

  

Total number of consultations with a rheumatologist in the last 12 months (n = 281)

0,165

  

0,163**

 0–1

0,86

(0,6-1,1)

 

0,85

(0,6-1,0)

 

 2–3

1

  

1

  

  ≥ 4

0,89

(0,7-1,0)

 

0,89

(0,7-1,0)

 

Disease time in months (n = 235)

0,247*

  

0,605**

 0–24

1

  

1

  

  > 24

1,16

(0,8-1,5)

 

1,07

(0,8-1,3)

 

Use of csDMARD (n = 296)

0,383*

  

0,283**

 Yes

1

  

1

  

 No

1,06

(0,9-1,2)

 

1,12

(0,9-1,3)

 

Use of TNFi (ADA + ETA+IFX) (n = 288)

0,960*

  

0,277**

 Yes

0,99

(0,8-1,1)

 

0,88

(0,7-1,0)

 

 No

1

  

1

  

HAQ (n = 165)

0,901*

  

0,587**

 0–1 (mild)

1

  

1

  

 1,1–2 (moderate)

0,89

(0,7-1,1)

 

0,86

(0,6-1,1)

 

 2,1–3 (severe)

1,01

(0,8-1,2)

 

0,92

(0,6-1,3)

 

Presence of radiological changes (erosions) in hands (n = 237)

0,814*

  

0,306**

 No

1

  

1

  

 Yes

0,98

(0,8-1,1)

 

1,13

(0,8-1,4)

 

Current professional situation (237)

0,324*

  

0,637**

 Working

1

  

1

  

 Health insurance

0,99

(0,7-1,2)

 

0,99

(0,7 – 1,4)

 

 Disability retirement

0,94

(0,7-1,1)

 

0,89

(0,6 – 1,1)

 

 Retirement for time of service

0,91

(0,7-1,1)

 

0,95

(0,7 – 1,2)

 
  1. csDMARD conventional synthetic disease-modifying antirheumatic drugs, TNFi tumor necrosis factor inhibitors, ADA adalimumab, ETA etanercept, IFX infliximab, HAQ health assessment questionnaire, PRc crude prevalence ratio, PRa adjusted prevalence ratio; CI 95%: confidence interval of 95%
  2. * Value of p > 0,20 excluded from the adjusted analysis. ** Value of p > 0,05 excluded of final model